Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Shengyang, China Clinical Trials

A listing of Shengyang, China clinical trials actively recruiting patients volunteers.

RESULTS

Found (5) clinical trials

Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis

This is a multicenter, randomized, openlabel, activecontrolled, parallel, phase III study which aims to assess the efficacy and safety of ferric citrate capsules for the treatment of hyperphosphatemia in patients with chronic kidney disease undergoing hemodialysis. This study is consisting of a Screening/Washout period (14 days) and a Treatment/Observation period ...

Phase

0.0 miles

Learn More »

A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)

The reason for this long term study is to see how safe and effective the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE) who have completed the final treatment visit of study I4V-MC-JAHZ (NCT03616912) or study I4V-MC-JAIA (NCT03616964).

Phase

1.73 miles

Learn More »

Standardization and Optimization of TMS Protocols for the Treatment of PD With Depression or Cognitive Impairment

Transcranial magnetic stimulation(TMS) is a valuable non-invasive brain stimulation tool for interventional neurophysiology applications, which generate local current and modulates brain activity in a specific, cortico-subcortical network. Repetitive TMS (rTMS) is developed as it is safe and well-tolerated. The left dorsolateral prefrontal cortex (DLPFC) high-frequency rTMS treatment has been proved ...

Phase N/A

1.73 miles

Learn More »

The Feasibility and Safety of Avoiding Chest Tube Placement After VATS Wedge Resection of the Lung

This is a prospective non-randomized controlled trial.The main study content is the feasibility and safety of avoiding chest tube placement after video-assisted thoracoscopic wedge resection of the lung,divided into experiment group and control group.Communicating the surgeon and patients who meet the inclusion criteria,decied whether to enter the experiment group or ...

Phase N/A

2.62 miles

Learn More »

Anlotinib Hydrochloride Combined With Epirubicin and Ifosfamide for Soft Tissue Sarcoma Patients

This study is planned to be carried out in Liaoning, Jilin and Harbin provinces regional multi-center. 47 cases are preliminarily expected to be included. The study started in January 2019 and ended in December 2019. It is expected that the trial will end in December 2020. This study is a ...

Phase

3.13 miles

Learn More »